Fibroids Treated With Uterine Artery Embolization: Do Imaging Findings Correlate With Patient Outcomes?

Millo N, Noam Millo, Boroditsky R, Richard Boroditsky, Edward A. Lyons, Lyons EA
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC · 2010 · vol. 32(5) , pp. 460–466 · doi:10.1016/s1701-2163(16)34500-5 · PMID:20500955 · W2157924548
article OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated the correlation between imaging findings after uterine artery embolization and patient outcomes for fibroid treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo evaluate whether changes on ultrasound in uterine and fibroid volume and fibroid vascularity correlate with changes in symptom severity and health-related quality of life (HRQL) perceived by patients after uterine artery embolization (UAE).Materials and methodsSixty-four women (mean age 45.3) with symptomatic uterine fibroids underwent UAE at the Hysterectomy Alternatives (HAlt) clinic in Winnipeg, Manitoba. They completed a validated questionnaire assessing symptom severity and HRQL at baseline and at three and six months post-embolization, and ultrasound was also performed at these intervals. Changes in uterine and fibroid volume were compared with changes in symptom severity and HRQL. Data from patients with residual fibroid vascularity, extremes of baseline fibroid volume, and concomitant adenomyosis were analyzed to determine whether the outcomes were different in these patient groups.ResultsChanges in uterine and fibroid volumes did not correlate with changes in symptom severity or HRQL after UAE (P > 0.05). Residual fibroid vascularity was a negative predictor of reduction in uterine and fibroid volume (P < 0.05), but did not affect changes in symptom severity or HRQL. Extremes of baseline volume in the dominant fibroid did not affect symptom severity or HRQL. Patients with concomitant adenomyosis experienced greater improvement in symptoms than those without adenomyosis (P < 0.05).ConclusionWe found poor correlation between imaging findings and patient- perceived outcomes after UAE. Ultrasound cannot be used to predict improvement in symptoms or HRQL after UAE.

My notes (saved in your browser only)

MeSH descriptors

Leiomyoma Leiomyoma Uterine Artery Embolization Uterine Neoplasms Uterine Neoplasms Female Humans Leiomyoma Leiomyoma Middle Aged Postoperative Period Quality of Life Severity of Illness Index Ultrasonography Uterine Neoplasms Uterine Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (21)

Cited by (6)

Source provenance

europepmc
last seen: 2026-08-02T06:10:09.037253+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:17:12.951333+00:00
License: CC0 · commercial use OK